Deepika Pakianathan, Director at OncoMed Pharmaceuticals Inc (OMED), bought 1,915,371 shares at $17.00 ($6.5M) on 2013-07-23, disclosed to the SEC on 2013-07-23.
Open-market purchase of $6.5M OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,533,018 | $0 | 0.0% |
| 2 | $17.00 | 3,226 | $55K | 0.8% |
| 3 | $17.00 | 379,127 | $6.4M | 99.2% |
| Total | $3.39 avg | 1,915,371 | $6.5M | 100% |
| Filing → |
| KPTI | SELL | 2024-06-04 | $1.4M | — | Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |